News

2022

Medaxes Day - 28/10/2022

Off-patent medicines: towards better accessibility, affordability and availability of quality treatments in Belgium

Jasmien Coenen_Managing Director_Medaxes_1 oktober 2022

Medaxes welcomes Jasmien Coenen as new Managing Director

Medaxes is pleased to announce that the Board of Directors has appointed Jasmien Coenen as the new Managing Director. She takes over the helm from Joris Van Assche who, to our great sadness, unexpectedly passed away on 8 August.

Decease of Joris Van Assche, our Managing Director

It is with great sadness that we inform you of the sudden decease of Joris Van Assche.

As Medaxes community, our thoughts are with his wife and children, his family and friends. We sincerely offer them our deepest sympathy.

There are no words for our disbelief and grief. Joris leaves a huge professional and personal void for us all. Not only was he our highly driven and unequalled Director, he was a warm-hearted man with the right values, a mediator and confidant for Medaxes and the whole community.

Thank you for everything, Joris. We will never forget you.

In an open letter, Medicines for Europe, the European umbrella organisation of off-patent medicine manufacturers, expresses its concern about the impact of sharply increasing costs for the production, transport and distribution of medicines.

Cheap medicines in particular are at risk of falling victim to this.

Essential medicines must be included in EU industrial policy plans

Off patent medicines account for 70% of those dispensed in Europe for the most prominent diseases such as cancer, diabetes, cardiovascular care, infectious diseases, and others. Between 70-90% of Intensive Care Unit (ICU), and emergency medicines are off patent. Our sector currently has over 400 manufacturing sites in Europe. Therefore, the off patent medicines industry sector must be included in the 'Important Project of Common European Interest' (IPCEI) on Health.

Please find here the press release of our European association, Medicines for Europe.

2021

Facts & Figures Generic medicines in Belgium

Scroll down or discover here the updated (October 2021) Facts & Figures Generic medicines in Belgium brochure.

 

Generic medicines day webinar of 28 October 2021 - Replay

Missed out on the Generic medicines day webinar of 28 October 2021?

Scroll down the homepage of our website to replay.

Generic medicines day webinar on 28 October 2021 at 12:30

Participate to the Generic medicines day webinar! Register now!

2020

fagg-afmps e-PIL call for candidates Medaxes

e-PIL project 2020

With the support of the Belgian and Luxembourg Competent Authorities, in 2018 the pharmaceutical industry launched the 'e-PIL' pilot project in Belgian and Luxembourg hospitals. The project is the result of a derogation obtained from the European Commission. 

GMD

Generic Medicines Day

Replay of the Generic Medicines Day webinar (in Dutch and French)

fagg-afmps e-PIL call for candidates Medaxes

e-PIL project 2020: call for candidates

With the support of the Belgian and Luxembourg Competent Authorities, in 2018 the pharmaceutical industry launched the 'e-PIL' pilot project in Belgian and Luxembourg hospitals. The project is the result of a derogation obtained from the European Commission. In this pilot project, a selection of medicines on the Belgian and Luxembourg market are not accompanied by their patient paper inserted leaflet (PIL). 

 

 

Coronavirus Medaxes members supply medicines

Treatment Covid-19: follow the scientific guidelines!

For the treatment of the Corona virus, Medaxes refers to the scientific guidelines issued by the scientific institutions of our country.

These informations are regularly updated, taking into account the latest scientific findings. For more information, please click on Sciensano Epidemio

/sites/default/files/styles/banner/public/2019-02/medaxes_news2.jpg?h=823e0b08&itok=zn1Lf5bc